menu
    • menu

    Company profile for Zenara Pharma

    NEW Drugs in Dev: 4
    Biophore Mix GIF-PSE
    News
    Zenara’s Generics Tafamidis Receives Tentative Approval in Us

    27 Oct 2025

    // FDA

    US FDA Approves Zenara Pharma's Generic Sertraline Hydrochloride

    05 Aug 2025

    // EXPRESSPHARMA

    Zenara Pharma Gets FDA Nod for First Generic Sertraline

    01 Aug 2025

    // PR NEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    Biophore

    Contact Supplier

    Website

    Asia Pharma Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/top-news-of-2025-drugmakers-invest-in-us-capacities-agree-to-lower-medicaid-prices-pfizer-buys-obesity-focused-biotech-metsera

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    Our state-of-the-art manufacturing facility at Cherlapally, Hyderabad is designed, equipped and maintained as per latest cGMP norms. The company’s manufacturing facility is fully equipped to manufacture both Solid Orals (Tablets, Capsules) and Oral liquids in various therapeutic categories. Zenara has in-house capability to ensure regulatory compliance in all the markets we operate in. We are constantly strengthening our global supply chain with customers in key markets including United States of America, Europe, Australia, New Zealand, Canada, Far East Asia, GCC (Gulf Cooperation Council), Brazil among others.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zenara Pharmaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot No.83/B, 84 & 87 to 96, Phase - III, IDA Cherlapally, Hyderabad - 500 051
    Telephone
    Telephone
    +91 4027260848
    Client Email
    Email
    info@biophore.com
    Client Website
    Website
    https://www.zenarapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zenara-pharma-pvt-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/home
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Zenara’s Generics Tafamidis Receives Tentative Approval in Us
    Zenara’s Generics Tafamidis Receives Tentative Approval in Us

    27 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205

    FDA
    27 Oct 2025
    Share Share
    US FDA Approves Zenara Pharma's Generic Sertraline Hydrochloride
    US FDA Approves Zenara Pharma's Generic Sertraline Hydrochloride

    05 Aug 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/zenara-pharma-receives-us-fda-approval-for-generic-sertraline-hydrochloride-capsules/

    EXPRESSPHARMA
    05 Aug 2025
    Share Share
    Zenara Pharma Gets FDA Nod for First Generic Sertraline
    Zenara Pharma Gets FDA Nod for First Generic Sertraline

    01 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zenara-pharma-receives-us-fda-approval--for-first-generic-of-sertraline-hydrochloride-capsules-with-180-day-cgt-exclusivity-302519297.html

    PR NEWSWIRE
    01 Aug 2025
    Share Share
    Zenara’s Receives First Generic Approval for Sertraline HCl in US
    Zenara’s Receives First Generic Approval for Sertraline HCl in US

    16 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=218853

    FDA
    16 Jul 2025
    Share Share
    Zenara`s Generics Sapropterin Receives Approval in US
    Zenara`s Generics Sapropterin Receives Approval in US

    11 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218797

    FDA
    11 Jun 2025
    Share Share
    Zenara`s Generics Nitazoxanide Receives Approval in US
    Zenara`s Generics Nitazoxanide Receives Approval in US

    03 Feb 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214844

    FDA
    03 Feb 2025
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zenara Pharma Gets US FDA Nod for First Generic Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

    Details:

    Sertraline HCl, a miscellaneous product targeting SSR, shows promising results in treating undisclosed Key Focus Area.


    Lead Product(s): Sertraline Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Sertraline-HCl

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 01, 2025

    Biophore CB

    01

    Zenara Pharma

    India
    arrow
    PharmaSynergy
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Sertraline Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Zenara Pharma Gets US FDA Nod for First Generic Sertraline Hydrochloride Capsules with 180-Day CGT...

    Details : Sertraline HCl, a miscellaneous product targeting SSR, shows promising results in treating undisclosed Key Focus Area.

    Product Name : Sertraline-HCl

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    August 01, 2025

    Biophore CB

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biophore, Its Subsidiary Zenara Pharma, Receive First Approval for Cannabidiol in India

    Details:

    Cannabinoid oral solution has received approval for the treatment of several neurological disorders. It functions by stimulating two receptors, cannabinoid receptor type 1 and type 2, within the endocannabinoid system, maintaining body's homeostatis.


    Lead Product(s): Cannabidiol

    Therapeutic Area: Rare Diseases and Disorders Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Controlled Substance

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 15, 2023

    Biophore CB

    02

    Zenara Pharma

    India
    arrow
    PharmaSynergy
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Cannabidiol

    Therapeutic Area : Rare Diseases and Disorders

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Biophore, Its Subsidiary Zenara Pharma, Receive First Approval for Cannabidiol in India

    Details : Cannabinoid oral solution has received approval for the treatment of several neurological disorders. It functions by stimulating two receptors, cannabinoid receptor type 1 and type 2, within the endocannabinoid system, maintaining body's homeostatis.

    Product Name : Undisclosed

    Product Type : Controlled Substance

    Upfront Cash : Inapplicable

    May 15, 2023

    Biophore CB

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zenara Launches Generic Version Of Pfizer Covid Drug Paxlovid

    Details:

    Paxzen (nirmatrelvir) is an oral protease inhibitor that is active against MPRO, a viral protease that plays an essential role in viral replication by cleaving the 2 viral polyproteins.


    Lead Product(s): Nirmatrelvir,Ritonavir

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Paxzen

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 09, 2022

    Biophore CB

    03

    Zenara Pharma

    India
    arrow
    PharmaSynergy
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Nirmatrelvir,Ritonavir

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Zenara Launches Generic Version Of Pfizer Covid Drug Paxlovid

    Details : Paxzen (nirmatrelvir) is an oral protease inhibitor that is active against MPRO, a viral protease that plays an essential role in viral replication by cleaving the 2 viral polyproteins.

    Product Name : Paxzen

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    September 09, 2022

    Biophore CB

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zenara Pharma to Launch Generic Paxlovid Soon

    Details:

    Zenara said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatment of mild-to-moderate Covid-19 in adults.


    Lead Product(s): Nirmatrelvir,Ritonavir

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Paxzen

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Pfizer Inc

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 28, 2022

    Biophore CB

    04

    Zenara Pharma

    India
    arrow
    PharmaSynergy
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Nirmatrelvir,Ritonavir

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Pfizer Inc

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Zenara Pharma to Launch Generic Paxlovid Soon

    Details : Zenara said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatment of mild-to-moderate Covid-19 in adults.

    Product Name : Paxzen

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    July 28, 2022

    Biophore CB

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zenara Pharma, a Biophore Subsidiary, Gets DCGI Nod for Favipiravir Tablets

    Details:

    Favipiravir tablets will be sold under the brand name ‘Favizen’, is being manufactured at Zenara’s US FDA approved facility in Hyderabad.


    Lead Product(s): Favipiravir

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Favizen

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 05, 2020

    Biophore CB

    05

    Zenara Pharma

    India
    arrow
    PharmaSynergy
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Favipiravir

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Zenara Pharma, a Biophore Subsidiary, Gets DCGI Nod for Favipiravir Tablets

    Details : Favipiravir tablets will be sold under the brand name ‘Favizen’, is being manufactured at Zenara’s US FDA approved facility in Hyderabad.

    Product Name : Favizen

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    August 05, 2020

    Biophore CB

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : BREXPIPRAZOLE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET;ORAL

    Brand Name : BREXPIPRAZOLE

    Dosage Strength : 0.25MG

    Packaging :

    Approval Date :

    Application Number : 213477

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : BREXPIPRAZOLE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET;ORAL

    Brand Name : BREXPIPRAZOLE

    Dosage Strength : 0.5MG

    Packaging :

    Approval Date :

    Application Number : 213477

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : BREXPIPRAZOLE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET;ORAL

    Brand Name : BREXPIPRAZOLE

    Dosage Strength : 1MG

    Packaging :

    Approval Date :

    Application Number : 213477

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : BREXPIPRAZOLE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET;ORAL

    Brand Name : BREXPIPRAZOLE

    Dosage Strength : 2MG

    Packaging :

    Approval Date :

    Application Number : 213477

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : BREXPIPRAZOLE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET;ORAL

    Brand Name : BREXPIPRAZOLE

    Dosage Strength : 3MG

    Packaging :

    Approval Date :

    Application Number : 213477

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : BREXPIPRAZOLE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET;ORAL

    Brand Name : BREXPIPRAZOLE

    Dosage Strength : 4MG

    Packaging :

    Approval Date :

    Application Number : 213477

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : CENOBAMATE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Brand Name : CENOBAMATE

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number : 219403

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : CENOBAMATE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Brand Name : CENOBAMATE

    Dosage Strength : 200MG

    Packaging :

    Approval Date :

    Application Number : 219403

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : CENOBAMATE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Brand Name : CENOBAMATE

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number : 219403

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : CENOBAMATE

    India
    arrow
    Paris Packaging Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Brand Name : CENOBAMATE

    Dosage Strength : 25MG

    Packaging :

    Approval Date :

    Application Number : 219403

    Regulatory Info :

    Registration Country : USA

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : BREXPIPRAZOLE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET; ORAL

    Proprietary Name : BREXPIPRAZOLE

    Dosage Strength : 0.25MG

    Approval Date :

    Application Number : 213477

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : BREXPIPRAZOLE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET; ORAL

    Proprietary Name : BREXPIPRAZOLE

    Dosage Strength : 0.5MG

    Approval Date :

    Application Number : 213477

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : BREXPIPRAZOLE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET; ORAL

    Proprietary Name : BREXPIPRAZOLE

    Dosage Strength : 1MG

    Approval Date :

    Application Number : 213477

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : BREXPIPRAZOLE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET; ORAL

    Proprietary Name : BREXPIPRAZOLE

    Dosage Strength : 2MG

    Approval Date :

    Application Number : 213477

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : BREXPIPRAZOLE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET; ORAL

    Proprietary Name : BREXPIPRAZOLE

    Dosage Strength : 3MG

    Approval Date :

    Application Number : 213477

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : BREXPIPRAZOLE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    BREXPIPRAZOLE

    Zenara Pharma

    Dosage Form : TABLET; ORAL

    Proprietary Name : BREXPIPRAZOLE

    Dosage Strength : 4MG

    Approval Date :

    Application Number : 213477

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : CENOBAMATE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Proprietary Name : CENOBAMATE

    Dosage Strength : 50MG

    Approval Date :

    Application Number : 219403

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : CENOBAMATE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Proprietary Name : CENOBAMATE

    Dosage Strength : 200MG

    Approval Date :

    Application Number : 219403

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : CENOBAMATE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Proprietary Name : CENOBAMATE

    Dosage Strength : 100MG

    Approval Date :

    Application Number : 219403

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : CENOBAMATE

    India
    PharmaSynergy
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CENOBAMATE

    Zenara Pharma

    Dosage Form : TABLET

    Proprietary Name : CENOBAMATE

    Dosage Strength : 25MG

    Approval Date :

    Application Number : 219403

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Biophore CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search